• Press Release

Brain Cancer Expert Joins Neurosurgery Faculty at Mount Sinai

  • New York, NY
  • (January 13, 2020)

Dolores Hambardzumyan, PhD, MBA, has been appointed Senior Faculty in the Department of Neurosurgery and a member of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. Her research focuses on developing novel therapeutic pathways for the treatment of glioblastoma, a type of brain tumor that is among the most deadly forms of human cancer. She is also exploring the relationship between cancer cells and immune cells within the tumor. Dr. Hambardzumyan’s laboratory explores the role of tumor-associated immune cells called macrophages in gliomas (a tumor that starts in the glial cells of the brain) using genetically engineered mouse models as well as cutting-edge imaging techniques and large-scale gene expression analysis.

“Our neurosurgery department fosters a close partnership between researchers and clinicians, and the addition of Dolores Hambardzumyan to our team further enhances our efforts to deliver cutting-edge treatments from the laboratory to the clinic,” said Joshua Bederson, MD, the Leonard I. Malis, MD / Corinne and Joseph Graber Professor of Neurosurgery at the Icahn School of Medicine at Mount Sinai, and Chair of Neurosurgery for the Mount Sinai Health System.  

“Despite the challenges in treating glioblastoma, the courage is getting up every day and working toward a cure,” said Dr. Hambardzumyan. “I am excited to join a world-class neurosurgery department that strives to make a difference in patient’s lives.”

Dr. Hambardzumyan received her PhD in Biochemistry from the Buniatian Institute of Biochemistry, part of the Armenian National Academy of Sciences. She received an MBA from Emory University’s Goizueta Business School. Her postgraduate training included fellowships in cancer biology and radiation oncology at Memorial Sloan Kettering Cancer Center and a fellowship in neuronal plasticity and transplantation at INSERM, the French National Institute of Health and Medical Research. She has ongoing R01 and R21 grants from the National Institutes of Health (NIH). She has 67 peer-reviewed contributions and is author of the chapter “Malignant Glioma” in the textbook Neuroglia, 3rd edition (2012).

The Department of Neurosurgery at the Mount Sinai Health System is internationally recognized as a leader in clinical neurosurgery, neurosurgery education, and neurosurgery research. The department has the largest volume of neurological surgeries in New York City. Neurosurgery and Neurology at The Mount Sinai Hospital were ranked 14th in the nation for neurological surgery in to the 2019-2020 “Best Hospitals” issue of U.S. News and World Report.


About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.